Context High-quality cancer care should be accessible for patients and healthcare professionals. Involvement of patients as partners in guideline formation and consensus processes is still rarely found. EURECCA, short for European Registration of Cancer Care, is the platform to improve outcomes of cancer care by reducing variation in the diagnostic and treatment process. EURECCA acknowledges the important role of patients in implementation of consensus information in clinical practice. Objective The aim of this article is to describe the process of involving patients in the consensus process and in developing the patient summary of the consensus for colon and rectal cancer care.
Introduction
Patient involvement is recognized as a crucial factor in delivering high-quality cancer management. In order to achieve the best possible cancer care, standards need to be clearly defined by both patients and professionals. Clinical guidelines and consensus conferences are an important part of this process. However, guidelines and consensus documents are usually written for healthcare professionals and are seldom accessible to patients in a 'patient friendly' manner or in lay language. As a result, patients do not have access to up-to-date information and may be unable to ask their clinical team the right questions.
Increasingly, patients are regarded as stakeholders and partners in the quest to improve the quality of their care [1] . Moreover, patients are increasingly invited to take part in individual clinical decision making, called shared decision making [2] . Decision aids, as an example, appear to have a positive effect on shared decision making and improve informed value-based choices [3] . For instance, websites such as 'Adjuvant Online' supply a decision-making tool for physicians and patients to estimate 'benefit or harm' for additional therapies, such as chemotherapy, after cancer surgery [4] . For patients to really take part in clinical decision making, we believe it is imperative that new information sources are converted into patient-friendly versions and delivered via diverse communication methods, including social media.
Another point of attention is that although healthcare professionals (doctors and specialised nurses) do their best to aid the patient, there might be an incongruity in patients' and doctors' preferences in clinical decision making.
Stalmeier et al. [5] elegantly studied a population of patients undergoing low-dose versus high-dose radiation therapy for prostate cancer to review doctors' perceptions of which the patient would choose. They concluded that physicians poorly predicted the preferences of patients using a decision aid. Physicians misjudged patients' decision-making preferences, and underestimated patients' preferences for the choice of treatment.
Having a patient summary of the latest consensus document for colon and rectal cancer care [6, 7] might assist this process and stimulate patients to ask questions that enable them to make decisions regarding their disease that fit their preferences.
With this in mind, we have prepared the ''Executive summary, especially written for patients, of the first multidisciplinary consensus conference on colon and rectal cancer care'' [6, 7] (see Electronic Supplementary Material [ESM]) to aid patients' understanding and clinical decision-making. The present article describes our consensus process involving patients (with colon and rectal cancer) and patient representatives in the multidisciplinary consensus process as a model for integration of the patients' voice in future consensus development.
Case Description of the Consensus Process
The consensus process was executed using the Delphi Method, which meant inviting a panel of experts to vote and comment on topics to achieve agreement [8] . To achieve this, the first multidisciplinary consensus meeting on colon and rectal cancer was organised in Italy [6, 7] .
The expert panel included delegates from the European Society of Surgical Oncology (ESSO), European Society for Radiotherapy and Oncology (ESTRO), European Society of Pathology (ESP), European Society for Medical Oncology (ESMO), European Society of Radiology (ESR), European Society of Coloproctology (ESCP), European CanCer Organisation (ECCO), European Oncology Nursing Society (EONS) and EuropaColon (European Colorectal Cancer Patient Organisation), as well as delegates from national registries or audits. The experts and delegates were invited to comment and vote on three web-based online voting rounds and to lecture on the subjects during the meeting (13-15 December 2012). The sentences in the consensus document were available during the meeting. A tele-voting round of the sentences where there was least agreement was organised during the conference for all participants of the meeting. The consensus document covers diagnostics, pathology, surgery, medical oncology, radiotherapy and follow-up where applicable for treatment of colon cancer, rectal cancer and metastatic colorectal disease, separately. Moreover, evidence-based algorithms for diagnostics and treatment were composed which were also submitted to the Delphi process.
In total, the members of the panel voted on 465 statements. All chapters were voted on by at least 75 % of the experts. Of the 465 statements, 84 % achieved large consensus, 6 % achieved moderate consensus, and 7 % resulted in minimum consensus. Disagreement by more than 50 % of the members was present in only 3 % of the statements [6, 7] . Table 1 and Fig. 1 present the steps in the Delphi method of achieving consensus. Organizing consensus conferences is one of the activities of EURECCA. EU-RECCA is the acronym for European Registration of Cancer Care, also known as European cancer audit [6, 9] . This is a multidisciplinary European platform developing a registry of cancer outcomes and providing feedback on performance of cancer care in various countries. The substantial variations in cancer treatments across Europe has resulted in large differences in cancer outcomes, such as survival [10, 11] .The goal of EURECCA is to reduce international variation in outcomes of cancer care, aiming to develop standards of care for both the diagnostic and treatment processes through consensus meetings.
Methods
This manuscript is a qualitative description of the process of involving patients in a European consensus process for multidisciplinary management of colon and rectal cancer care. The full clinical consensus document is published in the European Journal of Cancer [7] . It was unanimously agreed that we needed two versions of the consensus document, one for doctors and scientists and a second version for patients and their families.
Patient Involvement
We had two sorts of 'patient' representation in our process: patients who are true colon or rectal cancer survivors, who represent their own experience; and patient representatives who are working full time for EuropaColon, representing the 'collective voice of patients with colon or rectal cancer'.
Patients and patient representatives were involved at four different stages in the present consensus process: (1) to vote on and comment during the Delphi Method of achieving consensus, (2) to describe and debate during the meeting about the role of the patient in implementation of the consensus document, (3) to develop the patient summary, and (4) to develop future testing and implementation of the patient version.
Consensus Conference
The previous consensus meetings were 8 and 4 years ago and reported on rectal cancer treatment only [12] . The first multidisciplinary consensus conference on colon and rectal cancer care (CC3) was held in Perugia, Italy, December 2012 [7] . According to the Delphi Method, the expert panel represented leaders and scientists from all involved scientific societies, (for the full list please see the ESM), and patients representatives were invited (EuropaColon) to vote as well [13] . For the programme and the presentations of the meeting please visit the EURE-CCA website [14].
Delphi Method
Four researchers and three project leaders formed the scientific committee of the consensus conference of colon and rectal cancer. The preplanning of the actual Delphi method consisted of composing 465 evidence-based statements on pathology, diagnostics and treatment decisions for patients with colon and rectal cancer. The panel, consisting of medical experts in the field of colorectal cancer and patient representatives, voted and commented on these statements [7] . In addition, diagnostic and treatment algorithms to aid multidisciplinary teams in their decision making were created and voted upon as part of the process [7] . See Table 1 for the involvement of stakeholders (including patients and patient representatives) in the Delphi method and the scientific communications that were generated to achieve the consensus.
Using web-based online voting software, the members of the expert panel, including patient representatives, were invited to participate in three online voting and commenting rounds. During the meeting, panel members were invited to vote on the most controversial statements. Besides generating the consensus document, including the evidence-based recommendations on pathology, diagnostic and treatment processes, plans for implementation and monitoring the quality of care were incorporated into the process.
Development of the Patient Summary
Based on the recommendations from the consensus meeting, three authors started with the patient summary: one surgical oncologist, an oncology nurse and a patient representative. Several other clinicians (two surgical oncologists, a radiation oncologist and a medical oncologist) together with another patient representative and a former patient were consulted to ensure that the selection of statements and recommendations reflected the patients' decisions. After ensuring readability, EuropaColon approached survivors to respond to the patient summary. At least five patients responded by email to the patient summary, with their responses described in Table 3 , and these were incorporated into the patient summary.
Results
In the following sections, we describe how patients were involved in the consensus process and possible implications for further implementation of this guidance.
Patient Involvement in Various Stages
For an illustration of the consensus process and the patient involvement, see Fig. 1 . Please, note that 'Patients' also refers to the patient representative. Stage 2. In the final session of the meeting, an implementation session was organised. Patient representatives deliberated on implementation of the consensus document in the patient population; the PowerPoint presentation with text is provided in the ESM. Development of the patient summary was the next logical step.
Stage 3. There were too many statements (465) to translate them all into a lay version [7] . A selection of key decision points (around 10 %) was prepared with the nurse, patient representative and a surgeon, keeping in mind that this selection would become a tool for patients to discuss and decide on their own medical steps based on the consensus document. See Table 2 for the list of recommendations. Patients were consulted actively by email, and influenced the rewrite of the text and the topics in the patient version, envisioning that they would have had this document when first diagnosed with colorectal cancer. Table 3 contains quotes from patients (all rectal or colon cancer survivors) in response to the draft version and shows how these have influenced the final document. For example, a glossary was asked for and we have added this to the text. Five patients commented on the patient version from their own personal experience. Patients' comments have influenced the selection of upcoming topics for the next edition of the consensus conference, and these are also documented in Table 3 . In the patient summary, textboxes inform patients what questions to ask about the pathology report and what to think about at various stages of treatment. The full patient summary, including the evidence for several of these recommendations, can be found in the ESM.
Stage 4 Monitoring and evaluation of patient summary usefulness. This stage is mostly a work in progress. Two questionnaires were designed to test the helpfulness of the patient summary. One questionnaire is the short version examining the comprehensibility. The other questionnaire is asking for personal experiences, in which we are looking for patient-reported outcomes as well as testing each paragraph for usefulness. The results of these questionnaires will be incorporated in future editions of the patient version, thereby ensuring continuous up-to-date information consistent with patient preferences. We will ask our collaborators to distribute the patient summary and questionnaires to their patients, and we have included a link in the patient summary (for those patients who access the patient summary online; e.g., via the EuropaColon website) to feed their comments back to us.
Discussion
The present study describes the involvement of patients and patient representatives in the process and implementation of consensus on cancer care for colon and rectal cancer. The participation of patients and patient representatives has influenced our consensus process at several points, which we believe is important to focus the process on the needs of the patient. For future editions of the consensus, we will increase the influence of former patients and patient representatives by inviting them to contribute to the preplanning phase of topic and outcome selection. Implementation of consensus and guidelines can be Determining the metastatic stage (M) As part of your staging you may be offered a CT scan of your abdomen and a CT or X-ray of your chest; these are recommended to detect if there are any distant metastases If the pathology report shows a more extensive cancer or other high-risk prognostic factors (i.e., poor grade, blood or lymphatic vessel invasion) after local excision/TEM you should receive a TME after TEM anyway Treatment of T3 rectal cancer If you have a T3 rectal cancer, it can be managed in one of three ways: Surgery only followed by surveillance only A short course of radiotherapy treatment (5 days) before the operation, followed by immediate surgery A combination of chemotherapy and radiotherapy (CRT) followed by delayed (6-12 weeks) surgery
Margin positive in pathology If you have had a TME surgery for a rectal cancer, and receive a histopathology which reports a positive margin (CRM?), then postoperative radiotherapy treatment could be considered in a MDT discussion
Node positive in pathology You may be advised to consider adjuvant chemotherapy treatment after your surgery
Treatment of a T4 (and any nodal status) rectal cancer If you have a locally advanced cancer, you may need radiotherapy or chemo-radiation treatment to shrink or downsize the cancer and to offer you the possibility to become a surgical candidate after re-staging Referral to a tertiary centre has to be considered Follow-up of rectal cancer Discuss with your doctor after completion of the treatment which schedule (frequency and type of exams/tests) is best for you
We recommend that you have a colonoscopy at 3 years and then, if normal, once every 5/6 years thereafter Surgical treatment for liver ± lung metastases Ask whether your liver or lung metastases are resectable. If they are, then surgery should be offered
Chemotherapy combined with surgical treatment for liver ± lung metastases If you have a single small (\2 cm) liver metastasis, chemotherapy given intermittently for 6 months after surgery is recommended according to a MDT discussion If you have multiple metastases, consider having 3 months of preoperative chemotherapy, then a surgical resection of the metastases (if resectable by imaging or during surgery) followed by 3 months of postoperative chemotherapy
When surgical treatment of the metastases may not at first appear possible We advise that you have 3-4 months of chemotherapy prior to surgery if any metastases appear not to be easily resectable. After treatment, they can be re-scanned and if surgery is then possible, this should be planned with a thought to further chemotherapy afterwards, for a total duration of 6 months If any metastases remain unresectable after the first course of chemotherapy, the chemotherapy regimen should be changed, and the cancer re-scanned for possibility to resect according to a MDT discussion When there are metastases for which surgical treatment is not possible If the aim of your treatment is palliative rather than curative, then a strategy which plans to offer you a very active first-line chemotherapy treatment is recommended Fig. 2 ). Informing patients in lay language and measuring patient satisfaction should ideally be part of this process [19] . In our international consensus process we have actively involved patients and patient representatives to promote the implementation of the consensus document and attempted to also reach patients with our messages. Because the latter is our aim, we have not adopted the name 'research advocates' that is recommended by the National Cancer Institute, who recommend the use of this term for persons who bring a non-scientific viewpoint to the research process and communicate a collective 'patient' perspective. We think that the terms 'patient' and 'patient representative' are more accurate descriptions to capture the roles they had in the entire process. Although healthcare providers recognise that the involvement of the patient is increasingly shifting towards a dialogue, a lot of work still has to be done to make this common practice. Historically, patients were told what their treatment would encompass through a one-directional flow of information. However, with the internet as an emerging source of information, patients increasingly ''There seems to be a total absence of gastroenterologists as a medical speciality from the expert panel of health care professionals and scientists involved in colon and rectal cancer care. In Cyprus, after the pathologist (GP) the gastroenterologist is the one to perform examination and diagnostics such as colonoscopies and polyp removal. I believe reps of gastroenterologists should be involved by participating in the panel.''
One gastroenterologist was/is involved ''In cases where colostomies are performed especially permanent ones there is a need for providing sufficient information for the good management and care of the stoma including supplies as well as a follow up in maintenance.'' Future topic selection ''This is a extremely good document.'' Positive reinforcement ''The only thing wrong with it is that it has not been published ages before.'' Positive reinforcement ''When it comes to simplicity of expression and general understandability I think good work has been invested to reach this aim. The problem I have is that I'm considering myself to have a better command of English than the average of my fellow country people and you can't regard me as a standard and a good judge.'' Positive reinforcement ''By all means this is a perfect basis to go out from when it comes to develop presentations and other tutorial material for patients and also caretakers and other medical personnel.'' Implementation of consensus EGFR epidermal growth factor receptor, FU fluorouracil, SIRT selective internal radiation therapy 'Google' and 'Wiki' their diagnosis and can be more informed than their clinical team. While this growing enthusiasm to search for information is helping to empower patients, many sources of information are less than reliable and might lead false expectations that will take time to correct. Some research has shown that there are mixed views about the theories and measurements of the effects of patients' engagement in their treatment [3, 5, 20] , but it is generally agreed that greater engagement and patient empowerment is the desired direction and that this will enhance the patient/doctor relationship. Patient involvement and patient-doctor interaction are crucial for developing the role of the patient.
Conclusion
In conclusion, during the session of the multidisciplinary consensus conference on colon and rectal cancer care, we discussed the implementation of the Consensus Document in the patient population. With this manuscript and the patient summary, we fulfilled our goal to act upon several positions regarding patient involvement and ensuring accessibility to these standards of care. The description of our endeavour will hopefully function as a model for future consensus processes to involve patients at different stages and to implement both patient and doctor versions in daily practice. A plea to include the development of patientfriendly summaries of subsequent consensus documents is realised by this manuscript.
